Economic considerations and future directions for lung volume reduction surgery

References

• NHLBI and WHO. Global Initiative for Obstructive Lung Disease. 2003 Workshop Report (2003).
   Google Scholar
• ••Represents a state-of-the-art summaryoverview of all issues concerning chronic obstructive pulmonary disease.
   Google Scholar
• Murray CJ, Lopez AD. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020 (1996).
   Google Scholar
• Evidence based health policy — lessons from the global burden of disease study. Science 274, 740–743 (1996).
   PubMedGoogle Scholar
• Naunheim KS, Ferguson MK. The current status of lung volume operations for emphysema. Ann Thor. Sug. 62(2), 601–612 (1996).
   Google Scholar
• NHLBI. NHLBI: Morbidity and Mortality Chartbook on Cardiovascular; Lung and Blood Diseases 2002. (2002).
   Google Scholar
• Ramsey SD, Sullivan SD. The burden of illness and economic evaluation for COPD. Eur. Respir. J21, S29—S35 (2003).
   Google Scholar
• •Provides a good discussion of the type of economic issues in chronic obstructive pulmonary disease.
   Google Scholar
• Miravitlles M, Murio C, Guerrero T, Gisbert R. Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest 123,784–791 (2003).
   PubMed Web of Science ®Google Scholar
• Friedman M, Hillman DE. Economic burden of chronic obstructive pulmonary disease: impact of new treatment options. PharmacoEconomics 19(3), 245–254 (2001).
   PubMed Web of Science ®Google Scholar
• Hilleman DE, Dewan N, Malesker M, Friedman M. Pharmacoeconomic evaluation of COPD. Chest 118, 1278–1285 (2000).
   PubMed Web of Science ®Google Scholar
• Strassels SA, Smith DH, Sulliva SD, Mahajan PS. The costs of treating COPD in the United States. Chest 119,344–352 (2001).
   PubMed Web of Science ®Google Scholar
• Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 117, S5—S9 (2000).
   Google Scholar
• Sullivan SD, Strassels SA, Smith DH. Characterisation of the costs of chronic obstructive pulmonary disease (COPD) in the US. Eur. Respir. J. 9 (S23), 426 (1996).
   Google Scholar
• Office of National Statistics. Mortality statistics (revised) 1994: England and Wales. London, UK. Her Majesty's stationary office. (1996).
   Google Scholar
• Lofdahl C. Cost development of obstructive airways disease in Sweden. Eur. Respir Rev 6,113–115 (1996).
   Google Scholar
• Wouters EE Economic analysis of the Confronting COPD survey: an overview of results. Respir. Med. 97(Suppl. C), S3—S14 (2003).
   Google Scholar
• National Emphysema Treatment Trial Research Group. A randomised trial comparing lung-volume reduction surgery with medical therapy for severe emphysema. NEJM348(21), 2059–2073 (2003). The key large surgical trial.
   Google Scholar
• Brantigan OC, Mueller E. Surgical treatment of pulmonary emphysema. Am. Surg: 23,789–804 (1957).
   PubMedGoogle Scholar
• Brantigan OC, Mueller E, Kress MB. A surgical approach to pulmonary emphysema. Am. Rev. Resp. Dis. 80, 194–202 (1959).
   PubMed Web of Science ®Google Scholar
• Cooper JD, Trulock EP, Triantafillou AN. Bilateral pneumonectomy (volume reduction) for chronic obstructive pulmonary disease. j Thor Carrliovasc. Surg: 109,106-119 (1995).
   Google Scholar
• The National Emphysema Treatment Trial Research Group. Rationale and design of the National Emphysema Treatment Trial. A prospective randomised trial of lung volume reduction surgery. Chest 116, 1750–1761 (1999).
   Google Scholar
• Stirling G, Babidge WJ, Peacock MJ etal Lung volume reduction surgery in emphysema: a systematic review. Ann Thorac. Surg. 72,641–648 (2001).
   PubMedGoogle Scholar
• Young J, Fry-Smith A, Hyde C. Lung volume reduction surgery (LVRS) for chronic obstructive pulmonary disease (COPD) with underlying severe emphysema. Thorax 54(9), 779–789 (1999).
   PubMedGoogle Scholar
• Cooper JD, Lefrak SS. Lung-reduction surgery: 5 years on. Lancet 353, S26—S27 (1999).
   Google Scholar
• Criner G, Cordova S, Furukawa S. Prospective randomised trial comparing bilateral lung volume reduction surgery to pulmonary rehabilitation in severe chronic obstructive pulmonary disease. Am. J. Respir Cdr. Care Med. 160,2021–2027 (1999).
   Google Scholar
• Goodnight-White S, Jones WJ, Baaklini J. Prospective randomised controlled trial comparing bilateral lung volume reduction surgery (LVRS) to medical therapy alone in patients with severe emphysema. Chest118 (Suppl. 4), S102 (2000).
   Google Scholar
• Davies MG, Koyama H, Hansell DM. Lung volume reduction surgery in pulmonary emphysema: results of a randomised controlled trial. Am j Respir. Grit. Care Med. 161, A585 (2000).
   Google Scholar
• Lofdahl CG, Hillerdal G, Strom K. Randomised controlled trial of volume reduction surgery — preliminary results up to 12 months. Am. j Respir. Grit. Care Med. 161, A585 (2000).
   Google Scholar
• Pompeo E, Marino M, Nofroni I. Reduction pneumoplasty versus respiratory rehabilitation in severe emphysema: a randomised study. Ann Thorac. Surg. 70, 948–954 (2000).
   Google Scholar
• Berger RL, Celli BR, Meneghetti AL etal Limitations of randomized clinical trials for evaluating emerging operations: the case of lung volume reduction surgery. Ann Thorac. Surg: 72(2), 649–657 (2001).
   Google Scholar
• Cooper JD. Paying the piper: the NE1.1 strike a sour note. Ann Thorac. Surg: 72, 330–333 (2001).
   Google Scholar
• Sciurba FC. Patients at high risk of death after lung-volume reduction. Thomx57, S47—S52 (2002).
   Google Scholar
• Calverley PMA. Closing the NETT on lung volume reduction surgery. Thorax 58(8), 651–653 (2003).
   PubMedGoogle Scholar
• Cooper JD, Patterson GA, Sundarasen RS. Results of 150 consecutive lung volume reduction procedures in patients with severe emphysema. j Thorac. Carrliovasc. Surg: 112,1319-1330 (1996).
   Google Scholar
• Make BJ, Fein AM. Is volume reduction surgery appropriate in the treatmnet of emphysema? North Am. j Respir. Grit. Care Med. 153,1205–1207 (1996).
   PubMed Web of Science ®Google Scholar
• National Emphysema Treatment Trial Research Group. Cost effectiveness of lung volume reduction surgery for patients with severe emphysema. 1VEJM348(21), 2092-2102 (2003).
   Google Scholar
• ••The economic evaluation of the keysurgical trial.
   Google Scholar
• Pliskin JS, Stason WB, Weinstein MC. Coronary artery bypass graft surgery: clinical decision maknig and cost-effectiveness analysis. Med. Decis.Nlak. 1, 10–28 (1981).
   Google Scholar
• Weinstein MC, Stason WB. Cost- effectiveness of coronary artery bypass surgery. Circulation 66(Suppl. III), 56–66 (1982).
   Google Scholar
• Al MJ, Koopmanschap MA, van Enckeport PJ. Cost-effectiveness of lung transplantation in the Netherlands: a scenario analysis. Chest 113,124–130 (1998).
   PubMed Web of Science ®Google Scholar
• Ramsey SD, Patrick DL, Albert RK, Larson EB, Wood DE, Raghu G. The cost-effectiveness of lung transplantation: a pilot study. Chest 108,1594–1601 (1995).
   PubMed Web of Science ®Google Scholar
• Albert RK, Lewis S, Wood D, Benditt JO. Economic aspects of lung volume reduction surgery. Chest110, 1068–1071 (1996).
   PubMed Web of Science ®Google Scholar
• Elpern EH, Behner KG, Klontz B, Warren WH, Szidon JP, Kesten S. Lung volume reduction surgery: an analysis of hospital costs. Chest 113(4), 896–899 (1998).
   PubMedGoogle Scholar
• Brenner M, Gonzales X, Jones B etal Effects of a novel implantable elastomer device for lung volume reduction surgery in a rabbit model of elastase-induced emphysema. Chest 121(1), 201–209 (2002).
   PubMedGoogle Scholar
• Swanson SJ, Mentzer SJ, DeCamp MM etal No-cut thorascopic lung plication: a new technique for lung volume reduction surgery. jAm College Surgeons 185 (1), 25–32 (1997).
   Google Scholar
• Toma TP, Hopkinson NS, Hillier J et al Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 361 (9361), 931–933 (2003).
   PubMed Web of Science ®Google Scholar
• •Introduces the concept of non-invasive lung volume reduction surgery.
   Google Scholar
• Snell GI, Holsworth L, Borril ZL et al The potential for bronchoscopic lung volume reduction using bronchial prostheses: a pilot study. Chest 124(3), 1073–1079 (2003).
   PubMedGoogle Scholar
• Sabanathan S, Richardson J, Pieri-Davis S. Bronchoscopic lung volume reduction. J. Camliovas. Sing. 44(1), 101–108 (2003).
   Google Scholar
• Evaluation of a novel intra-bronchial valve to produce lung volume reduction. 12th World Congress of Bronchology June 16–19, 2002. Boston, MA, USA (2002).
   Google Scholar
• Ingenito EP, Reilly JJ, Mentzer SJ etal Bronchoscopic volume reduction: a safe and effective alternative to surgical therapy for emphysema. Am. J. Respir. Grit. Care Med. 164(2), 295–301 (2001).
   Google Scholar
• Ingenito EP, Berger RL, Henderson AC, Reilly JJ, Tsai L, Hoffman A. Bronchoscopic lung volume reduction using tissue engineering principles. Am. J. Respir. Crit. Cam Med. 167(5), 771–778 (2003). 50Macklem PT Collateral ventilation. NEJM 298(1), 49–50 (1978).
   Google Scholar
• Lausberg HF, Chino K, Patterson GA, Meyers BE Bronchial fenestration improves expiratory flow in emphysematous human lungs. Ann Thor. Surg. 75,393–398 (2003).
   PubMed Web of Science ®Google Scholar
• Centers for Medicare and Medicaid Services. National coverage analysis: lung volume reduction surgery. (2003).
   Google Scholar
• Hurd S. The impact of COPD on lung health worldwide: epidemiology and incidence. Chest 117(2), S1—S4 (2000).
   Google Scholar
• Munro P, Bailey M, Smith J, Snell G. Lung volume reduction surgery in Australia and New Zealand: six years on. Chest an Press) (2003).
   Google Scholar
• Morera J. Enfermedad pulmonar obstructiva cronica: magnitud del problemar. Enfermedad pulmonar obstructiva cronica: conceptos generales. 1, 57–65 (1992).
   Google Scholar
• Jacobson L, Hertzman P, Lofdahl C. The economic impact of asthma and chronic obstructive pulmonary disease in Sweden in 1980 and 1991. Respir. Med. 94,247-255 (2000).
   Google Scholar
• Wilson L, Devine E, Therefore K. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema. Respir. Med. 94,204-213 (2000).
   Google Scholar
• Rutten-van Molken M, Postma M, Joore M. Current and future medical costs of asthma and chronic obstructive pulmonary disease in the Netherlands. Respir. Med. 93, 779–787 (1999).
   Google Scholar